期刊
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
卷 73, 期 4, 页码 457-476出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jacc.2018.10.075
关键词
cardiovascular medications; gestation; pharmacokinetics; pregnancy
Cardiovascular disease complicating pregnancy is rising in prevalence secondary to advanced maternal age, cardiovascular risk factors, and the successful management of congenital heart disease conditions. The physiological changes of pregnancy may alter drug properties affecting both mother and fetus. Familiarity with both physiological and pharmacological attributes is key for the successful management of pregnant women with cardiac disease. This review summarizes the published data, available guidelines, and recommendations for use of cardiovascular medications during pregnancy. Care of the pregnant woman with cardiovascular disease requires a multidisciplinary team approach with members from cardiology, maternal fetal medicine, anesthesia, and nursing. (c) 2019 by the American College of Cardiology Foundation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据